| Metric | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|
| Revenue | $7.4B | $6.7B | $5.0B |
| Cost of Revenue | $5.5B | $4.9B | $3.7B |
| Gross Profit | $2.0B | $1.8B | $1.3B |
| R&D Expense | — | — | — |
| SG&A Expense | $1.1B | $0.9B | $0.7B |
| Operating Income | $0.7B | $0.8B | $0.4B |
| Net Income | $0.4B | $0.4B | $0.1B |
| EPS (Basic) | $2.14 | $2.16 | $0.57 |
| EPS (Diluted) | $2.13 | $2.13 | $0.55 |
| Metric | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|
| Total Assets | $5.9B | $4.9B | $4.4B |
| Current Assets | $2.0B | $2.2B | $1.8B |
| Cash & Equivalents | $0.0B | $0.2B | $0.0B |
| Total Liabilities | $4.1B | $2.5B | $2.6B |
| Current Liabilities | $0.9B | $0.7B | $0.8B |
| Stockholders' Equity | $1.7B | $1.7B | $1.3B |
| Metric | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.4B | $-0.0B |
| Investing Cash Flow | $-0.8B | $-0.2B | $-0.2B |
| Capital Expenditures | — | — | — |
| Financing Cash Flow | $0.2B | $-0.1B | $-0.1B |